Addex Therapeutics Is A Clinical Stage Biopharmaceutical Company Based In Genevaswitzerlandthe Company Focuses On Developing And Commercializing Innovative Orally Available Small Molecule Drugs Known As Allosteric Modulatorsaimed At Treating Neurological Disorderskey Areas Of Focus Include Glutamate Receptorsparkinson S Disease Treatmentsand Central Nervous System Disorders The Company S Pipeline Features Several Drug Candidatesincluding Dipraglurant For Parkinsonae S Disease Levodopa Induced Dyskinesia And Post Stroke Recoveryadx71149 For Epilepsy Developed In Partnership With Janssen Pharmaceuticalsand A Gabab Pam Program For Chronic Cough And Substance Use Disorders In Collaboration With Indivioraddex Therapeutics Generates Revenue Through Research And Development Collaborationslicensing Agreementsand Anticipates Future Product Sales As Its Pipeline Progressesthe Company Has Established Strategic Partnerships With Notable Pharmaceutical Firmsincluding Janssenindiviormerck Kgaaand Novartis
No conferences found for this company.
| Company Name | Addex Pharmaceuticals Sa |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
